Introduction
Isothermal Nucleic
Acid Amplification Technology (INAAT) is a molecular diagnostic technique that
amplifies a specific sequence of nucleic acid in a sample using a single
temperature reaction. This technology offers significant advantages over
traditional PCR-based methods, such as faster amplification times, greater
specificity, and reduced equipment requirements.
Global INAAT Market Overview
The Isothermal Nucleic Acid
Amplification Technology/INAAT Market is
expected to grow from USD 1.9 billion in 2019 to USD 3.3 billion by 2024, at a
CAGR of 11.0% during the forecast period.
Factors such as the
rising prevalence of infectious diseases and the introduction of newer
pathogens, the need for prompt diagnosis, the increasing number of blood
transfusions and donations, and the cost-benefits of INAAT are the key factors
driving the market growth.
Ask
for PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=839
Market
Segmentations:-
Based on the product,
the INAAT market is segmented into assay, kits, and reagents,
and systems. Assay, kits, and reagents segment are expected to account for the
largest share of the INAAT industry in 2019, Based on the type, the global
market is divided into TMA, LAMP, SDA, HAD, NASBA, and other technologies.
Based on application,
the INAAT market is segmented into infectious disease diagnosis, blood
screening, and other applications such as cancer diagnosis, cancer research,
and laboratory research, which encompass cDNA preparation, whole-genome
amplification (WGA), single-nucleotide polymorphism (SNP), and mutation
analysis.
Based on the end user,
the market is divided into hospitals, reference laboratories, academic and
research institutes, and other end users.
Regional
Analysis: -
In 2019, North America
is expected to account for the largest share of the global INAAT market,
followed by Europe.
Recent Developments:
- In 2019, Hologic (US) launched Aptima BV
and Aptima CV/TV Assays
- In 2018, Grifols (Spain) ) launched
Procleix Babesia assay
- In 2018, Tecan Trading AG (Switzerland)
acquired Nugen Technologies (US) which helped the company to enhance its
next-generation sequencing reagents portfolio. This development helped the
company to accelerate its broad genomics strategy.
- In 2016, Eiken Chemicals (Japan) signed a
distribution agreement with HUMAN (Germany), for distribution of
loop-mediated isothermal amplification-based tuberculosis and
malaria molecular diagnostic systems in the global market
(except in Japan, China, Korea, Taiwan, and Thailand).
Request
for Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=839
Top
Key Players: -
The major companies in
the global INAAT market include Grifols S.A. (Spain), Hologic, Inc. (US),
Abbott Laboratories, Inc. (US), Becton, Dickinson & Company (US), and
Meridian Bioscience (US).
Conclusion:
In conclusion,
Isothermal Nucleic Acid Amplification Technology (INAAT) is a rapidly growing
field in molecular diagnostics. The advantages of INAAT over traditional
PCR-based methods have contributed to its increasing adoption in the healthcare
industry, especially in low-resource settings. The INAAT market is expected to
continue to grow rapidly in the coming years, driven by factors such as the
increasing prevalence of infectious diseases, the need for accurate and
cost-effective diagnostic methods, and the rising demand for point-of-care
testing.
